Abstract:Background: Microparticles (MPs) are small extracellular plasma membrane particles shed by activated and apoptotic cells, which are involved in the development of atherosclerosis. Our previous study found that microRNA (miR)-19b encapsulated within endothelial MPs (EMPs) may contribute to the upregulation of circulating miR-19b in unstable angina patients. Hypoxia is involved in atherosclerosis as a critical pathological stimulus. However, it still remains unclear whether the increase of miR-19b levels in EMPs is related to hypoxia and if the effect of miR-19b u wrapped within EMPs u stimulates hypoxia on vascular endothelial cells. This study aimed to explore the changes of miR-19b in EMPs induced by hypoxia as well as their effects on endothelial cells. Methods: Human umbilical vein endothelial cells (HUVECs) were cultured in vitro and arranged to harvest EMPs in two parts: the first part consisted of EMPcontrol and EMPhypoxia and the second part included EMPvehicle, EMPNC mimic, and EMPmiR-19b mimic. Cell migration was detected by scratch migration and transwell chamber migration. Angiogenesis was assessed by tube formation assays. Furthermore, we predicted the target gene of miR-19b by bioinformatics analysis, and luciferase assay was used to verify the targeted gene of miR-19b. Data were analyzed by one-way analysis of variance. Student's t-test was used when two groups were compared. Results: Compared with EMPcontrol- and EMPhypoxia-inhibited migration of cells by scratch migration assay (80.77 1.10 vs. 28.37 1.40, P < 0. 001) and transwell chamber migration assay (83.00 3.46 vs. 235.00 16.52, P < 0.01), the number of tube formations was markedly reduced by 70% in the EMPhypoxia group (P < 0.001) in vitro analysis of HUVECs. Meanwhile, a strong inhibition of migration and tube formation of HUVECs in the presence of miR-19b-enriched EMPmiR-19b mimic was observed. This effect might be due to the delivery of miR-19b in EMPs. Transforming growth factor-2 (TGF2) was predicted to be one of the target genes of miR-19b, and we further confirmed that TGF2 was a direct target gene of miR-19b using the luciferase assay. The expression of TGF2 in HUVECs was inhibited by treatment with EMPhypoxia and EMPmiR-19b mimic. Conclusions: MiR-19b in EMPs induced by hypoxia could reduce endothelial cell migration and angiogenesis by downregulating TGF2 expression, which may have inhibited the progression of atherosclerosis.

Research Developments of Vascular Endothelial Microparticles

Role of Specific Micrornas for Endothelial Function and Angiogenesis

Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging

Increased Circulating CD31bright/Annexin V+ Endothelial Microparticles in Patients with Coronary Artery Disease

Research progress in circulating microparticles

Advances in the study of microparticles in diabetic retinopathy

Oxidized Low-Density Lipoprotein-Induced Microparticles Promote Endothelial Monocyte Adhesion Via Intercellular Adhesion Molecule 1.

Association of Endothelial Microparticle with NO, Enos, ET-1, and Fractional Flow Reserve in Patients with Coronary Intermediate Lesions

Exosomes and Their Derivatives As Biomarkers and Therapeutic Delivery Agents for Cardiovascular Diseases: Situations and Challenges.

Emerging Role of Exosome-Mediated Intercellular Communication in Vascular Remodeling

Microparticles (Exosomes) and Atherosclerosis

Endothelial Microparticles after Antihypertensive and Lipid-Lowering Therapy Inhibit the Adhesion of Monocytes to Endothelial Cells

Sirt6 Mrna-Incorporated Endothelial Microparticles (emps) Attenuates DM Patient-Derived EMP-induced Endothelial Dysfunction

Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis

Endothelial progenitor cell-derived extracellular vesicles: the world of potential prospects for the treatment of cardiovascular diseases

The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics

Effect of Endothelial Microparticles Induced by Hypoxia on Migration and Angiogenesis of Human Umbilical Vein Endothelial Cells by Delivering MicroRNA-19b.

Mesenchymal Stem Cell–derived Extracellular Vesicles: a New Impetus of Promoting Angiogenesis in Tissue Regeneration

Bioactive compounds and biological functions of medicinal plant-derived extracellular vesicles

Increased Circulating CD31~(bright)/Annexin V~+ Endothelial Microparticles in Patients with Acute Coronary Syndromes

Therapeutic potential and pharmacological significance of extracellular vesicles derived from traditional medicinal plants